Chemotherapy or Allogeneic Stem Cell Transplantation as Salvage Therapy for Patients with Refractory Acute Myeloid Leukemia: A Multicenter Analysis

INTRODUCTION: The overall outcome of patients with refractory AML (rAML) remains poor. Though allogeneic hematopoietic stem cell transplantation (allo-HSCT) is considered as the only curative therapy, it is routinely recommended only for patients after remission with salvage chemotherapy. OBJECTIVE:...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhong-yu, Gao, Wen-hui, Zhao, Hui-jin, Yin, Chun-rong, Wang, Zi-wei, Tian, Liang, Wang, Ling, Wang, Li-ning, Jiang, Jie-ling, Devillier, Raynier, Wan, Ming, Wang, Jian-Ming, Huang, Ping-ping, Blaise, Didier, Hu, Jiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393842/
https://www.ncbi.nlm.nih.gov/pubmed/35231903
http://dx.doi.org/10.1159/000511144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393842/
https://www.ncbi.nlm.nih.gov/pubmed/35231903
http://dx.doi.org/10.1159/000511144

Ejemplares similares